Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis
Authors:
Open Access
- 17 January 2024
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 22 (5) , 1048-1057.e2
Abstract
No abstract availableKeywords
Funding Information
- Vetenskapsrådet
This publication has 25 references indexed in Scilit:
- Phosphatidylethanol is Superior to Carbohydrate‐Deficient Transferrin and γ‐Glutamyltransferase as an Alcohol Marker and is a Reliable Estimate of Alcohol Consumption LevelAlcohol, Clinical and Experimental Research, 2015
- Phosphatidylethanol Compared with Other Blood Tests as a Biomarker of Moderate Alcohol Consumption in Healthy Volunteers: A Prospective Randomized StudyAlcohol and Alcoholism, 2015
- Global burden of alcoholic liver diseasesJournal of Hepatology, 2013
- Phosphatidylethanol in Blood as a Marker of Chronic Alcohol Use: A Systematic Review and Meta-AnalysisInternational Journal of Molecular Sciences, 2012
- Monitoring of the Alcohol Biomarkers PEth, CDT and EtG/EtS in an Outpatient Treatment SettingAlcohol and Alcoholism, 2012
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- Body mass index and risk of liver cirrhosis in middle aged UK women: prospective studyBMJ, 2010
- The Swedish personal identity number: possibilities and pitfalls in healthcare and medical researchEuropean Journal of Epidemiology, 2009
- Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver diseaseScandinavian Journal of Gastroenterology, 2009
- PHOSPHATIDYLETHANOL (PEth) CONCENTRATIONS IN BLOOD ARE CORRELATED TO REPORTED ALCOHOL INTAKE IN ALCOHOL-DEPENDENT PATIENTSAlcohol and Alcoholism, 2006